BIOMAT Database Logo BIOMAT Database Logo

Cell-associated ceramide in HIV-1-infected subjects. 1996

C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi

UI MeSH Term Description Entries
D008297 Male Males
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002518 Ceramides Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE. Ceramide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Cell cycle distribution of CD4+ lymphocytes in HIV-1-infected subjects.
November 2004, Cytometry. Part B, Clinical cytometry,
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen.
September 1999, AIDS (London, England),
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Granulocyte-associated immunoglobulins in asymptomatic HIV-infected subjects.
January 1989, Nouvelle revue francaise d'hematologie,
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Is the telomere length associated with neurocognitive disabilities in HIV-1-infected subjects?
January 2018, Revista do Instituto de Medicina Tropical de Sao Paulo,
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Red cell autoantibodies in asymptomatic HIV-infected subjects.
June 1989, Transfusion,
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Contact dermatitis in subjects infected with HIV type 1.
May 1999, Journal of the American Academy of Dermatology,
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects.
March 2000, Clinical and diagnostic laboratory immunology,
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
September 2002, AIDS (London, England),
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.
November 2001, Proceedings of the National Academy of Sciences of the United States of America,
C De Simone, and M G Cifone, and E Alesse, and S M Steinberg, and L Di Marzio, and S Moretti, and G Famularo, and A Boschini, and R Testi
Cytokine detection in HIV-1/HHV-8 co-infected subjects.
September 2002, Cell biochemistry and function,
Copied contents to your clipboard!